The following data is part of a premarket notification filed by Sequenom, Inc. with the FDA for Impact Dx Factor V Leiden And Factor Ii Genotyping Test.
Device ID | K132978 |
510k Number | K132978 |
Device Name: | IMPACT DX FACTOR V LEIDEN AND FACTOR II GENOTYPING TEST |
Classification | System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations |
Applicant | SEQUENOM, INC. 3595 JOHN HOPKINS COURT San Diego, CA 92121 |
Contact | Robin Weiner |
Correspondent | Robin Weiner SEQUENOM, INC. 3595 JOHN HOPKINS COURT San Diego, CA 92121 |
Product Code | PHJ |
CFR Regulation Number | 864.7280 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2013-09-23 |
Decision Date | 2014-06-13 |
Summary: | summary |